Study period (weeks) | ||||||
---|---|---|---|---|---|---|
Visit # | Screening | 1, 2 | 3, 4 | 4 week wash out | 5, 6 | 7, 8 |
Study week | 0 | 4 (+ 5 / -2 days) | 9 (+ 5 / -2 days) | 12 (+ 5 / -2 days) | ||
Informed consent, demographic information, inclusion/exclusion criteria, and medical history | + | |||||
Vital signs and anthropometric measures (body weight, hip and waist circumference, BMI, blood pressure, arterial stiffness) | + | + | + | + | + | |
Concomitant medications | + | + | + | + | + | |
Genotyping of DNA samples | + | |||||
Blood lipid profile (TG, TC, LDL-C, HDL-C) and glucose | + | + | + | + | + | |
Blood sterol and sterol precursor profile | + | + | + | + | ||
Gastrointestinal (GI) tolerability questionnaires | + | + | + | + | ||
Treatment Dispensation | + | + | ||||
Treatment Accountability (Participant Consumption Checklist) | + | + | ||||
treatment checklists | + | + | ||||
Adverse events | + | + | ||||
Study termination | + |